Eagle Health Investments’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Eagle Health Investments’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-579,769	Closed	-$12.4M	–	31
2024 Q1	$12.4M	Hold	579,769	–	–	2.3%	18
2023 Q4	$5.57M	Hold	579,769	–	–	1.13%	19
2023 Q3	$1.51M	Sell	579,769 -100,601	-15%	-$323K	0.33%	23
2023 Q2	$3.18M	Buy	+680,370	New	+$2.94M	0.59%	24

Eagle Health Investments's FUSN Position: Q2 2024 in Review

Eagle Health Investments sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 579,769 shares — an estimated $12.4M sold.

Eagle Health Investments first reported a position in FUSN in Q2 2023 and held it in 4 quarters. The position peaked at $12.4M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Eagle Health Investments reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Eagle Health Investments sold 579,769 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $12.4M.
Eagle Health Investments first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2023 and held it in 4 quarters.
Eagle Health Investments's Fusion Pharmaceuticals Inc. Common Shares position peaked at $12.4M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Eagle Health Investments's 13F filing for Q2 2024, filed 13 Aug 2024.